Updated Jul 16, 2026 · Last SEC filing 2026-07-15
UNITED THERAPEUTICS Corp (UTHR) has filed 93 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-15. 2 Form 8-K material event filings were reported by UTHR in the last 90 days. 12 Form 144 notices of proposed sale were filed for UTHR stock. InsiderAlpha tracks every UTHR SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001082554 |
| Form 4 filings (90d) | 93 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 12 |
| Latest Form 4 filing | 2026-07-15 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| ROTHBLATT MARTINE A | Chairperson & CEO | S — Open-market sale [10b5-1] | 840 | $524.15 | $440K | SEC | |
| ROTHBLATT MARTINE A | Chairperson & CEO | M — Option exercise [10b5-1] | 9.5K | $135.42 | $1.29M | SEC | |
| ROTHBLATT MARTINE A | Chairperson & CEO | S — Open-market sale [10b5-1] | 959 | $529.21 | $508K | SEC | |
| ROTHBLATT MARTINE A | Chairperson & CEO | S — Open-market sale [10b5-1] | 200 | $532.60 | $107K | SEC | |
| ROTHBLATT MARTINE A | Chairperson & CEO | S — Open-market sale [10b5-1] | 1.5K | $525.16 | $771K | SEC | |
| ROTHBLATT MARTINE A | Chairperson & CEO | S — Open-market sale [10b5-1] | 3.5K | $526.13 | $1.84M | SEC | |
| ROTHBLATT MARTINE A | Chairperson & CEO | S — Open-market sale [10b5-1] | 1.2K | $527.06 | $643K | SEC | |
| ROTHBLATT MARTINE A | Chairperson & CEO | S — Open-market sale [10b5-1] | 660 | $528.13 | $349K | SEC | |
| ROTHBLATT MARTINE A | Chairperson & CEO | S — Open-market sale [10b5-1] | 554 | $530.67 | $294K | SEC | |
| ROTHBLATT MARTINE A | Chairperson & CEO | S — Open-market sale [10b5-1] | 107 | $531.08 | $57K | SEC | |
| ROTHBLATT MARTINE A | Chairperson & CEO | M — Option exercise [10b5-1] | 9.5K | $135.42 | $1.29M | SEC | |
| ROTHBLATT MARTINE A | Chairperson & CEO | S — Open-market sale [10b5-1] | 40 | $542.80 | $22K | SEC | |
| ROTHBLATT MARTINE A | Chairperson & CEO | S — Open-market sale [10b5-1] | 1.0K | $533.70 | $544K | SEC | |
| ROTHBLATT MARTINE A | Chairperson & CEO | S — Open-market sale [10b5-1] | 409 | $538.60 | $220K | SEC | |
| ROTHBLATT MARTINE A | Chairperson & CEO | S — Open-market sale [10b5-1] | 665 | $537.66 | $358K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for UNITED THERAPEUTICS Corp (UTHR). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| ROTHBLATT MARTINE A | 704 | $373.81M |
| EDGEMOND JAMES | 255 | $137.50M |
| MAHON PAUL A | 57 | $29.22M |
| PATUSKY CHRISTOPHER | 8 | $2.63M |
| MALCOLM JAN | 3 | $179K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in UTHR insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live UTHR dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.